(Q47310602)

13 January 2018

title

The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

12 August 2023

0 references

D. A. Johnson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135298

12 August 2023

G. Pasterski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135298

12 August 2023

J. M. Ludlow

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135298

12 August 2023

K. Street

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135298

12 August 2023

R. D. Taylor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135298

12 August 2023

language of work or name

English

0 references

publication date

1 May 1983

1 reference

13 January 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0447.1983.tb00351.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0447.1983.tb00351.x/fullpdf

12 August 2023

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

Acta Psychiatrica Scandinavica

12 August 2023

published in

1 reference

13 January 2018

volume

67

1 reference

13 January 2018

issue

5

1 reference

13 January 2018

page(s)

339-352

1 reference

13 January 2018

Overview: maintenance therapy in psychiatry: I. Schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1983.TB00351.X

Fluphenazine decanoate, fluphenazine hydrochloride given orally, and placebo in remitted schizophrenics. I. Relapse rates after one year

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1983.TB00351.X

Drug and sociotherapy in the aftercare of schizophrenic patients. III. Adjustment of nonrelapsed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1983.TB00351.X

Antiparkinsonian agents and depot phenothiazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1983.TB00351.X

Tardive dyskinesia: are first signs reversible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1983.TB00351.X

An assessment of tardive dyskinesia in schizophrenic outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1983.TB00351.X

Tardive dyskinesia--reversible and persistent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1983.TB00351.X

Low dose fluphenazine decanoate in maintenance treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1983.TB00351.X

21 January 2018

1

3

559

Leff J P

1977

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.

12 August 2023

2

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

The Expectation of Outcome from Maintenance Therapy in Chronic Schizophrenic Patients

12 August 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

Further Observations on the Duration of Depot Neuroleptic Maintenance Therapy in Schizophrenia

12 August 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

Long-term fluphenazine decanoate maintenance dosage requirements of chronic schizophrenic patients

12 August 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients

12 August 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

Tardive Dyskinesia: An Evaluation of the Etiologic Association with Neuroleptic Therapy

12 August 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia

12 August 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

An experimental model of tardive dyskinesia

12 August 2023

25

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

The assessment of tardive dyskinesia

12 August 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

12 August 2023

Danish medical bulletin

29

46

209

Gerlach J

1979

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

Tardive dyskinesia: summary of a Task Force Report of the American Psychiatric Association. By the Task Force on Late Neurological Effects of Antipsychotic Drugs

12 August 2023

32

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

The disabilities of chronic schizophrenia--their nature and the factors contributing to their development.

12 August 2023

33

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia

12 August 2023

35

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

Studies of depressive symptoms in schizophrenia

12 August 2023

36

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

'Revealed' Depression and Drug Treatment for Schizophrenia

12 August 2023

37

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

Depression 'revealed' in schizophrenia

12 August 2023

38

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

A standardized psychiatric assessment scale for rating chronic psychotic patients

12 August 2023

40

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

A rating scale for extrapyramidal side effects

12 August 2023

41

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

Role of fluphenazine decanoate in lessening the burden of chronic schizophrenics on the community

12 August 2023

43

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

NEUROMUSCULAR EFFECTS OF LONG-TERM PHENOTHIAZINE MEDICATION, ELECTROCONVULSIVE THERAPY AND LEUCOTOMY

12 August 2023

44

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB00351.X

12 August 2023

Identifiers

1 reference

13 January 2018

1 reference

13 January 2018